SCHEMBL26548860

SCHEMBL26548860

C[Si](C)(C)c1ccc(-c2ccc3ccc(-c4ccc(-c5cc(C(F)(F)F)cc(C(F)(F)F)c5)nc4)cc3c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 5/20 0.43
TDO2 P48775 2/20 0.39
IDO1 P14902 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
S1PR1 P21453 2/20 0.34
ALOX5AP P20292 2/20 0.34
FEN1 P39748 2/20 0.34
TEK Q02763 1/20 0.34
MAOB P27338 2/20 0.33
RXRA P19793 2/20 0.33
RXRB P28702 2/20 0.33
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33
PGR P06401 1/20 0.33
RXRG P48443 1/20 0.33
NPBWR1 P48145 1/20 0.33
KIF11 P52732 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26548855 0.95 TDO2 (0.42) KDM1ATDO2IDO1TDP1S1PR1
SCHEMBL26548369 0.91 TDO2 (0.43) KDM1ATDO2IDO1TDP1S1PR1
SCHEMBL26548850 0.91 TDO2 (0.45) KDM1ATDO2IDO1ALOX5APFEN1
SCHEMBL26548845 0.91 TDO2 (0.45) KDM1ATDO2IDO1ALOX5APFEN1
SCHEMBL26548858 0.89 KDM1A (0.47) KDM1ATDO2IDO1TDP1ALOX5AP
SCHEMBL26548862 0.89 KDM1A (0.49) KDM1ATDO2IDO1TDP1S1PR1
SCHEMBL26548856 0.86 TDP1 (0.47) KDM1ATDO2IDO1TDP1TEK
SCHEMBL26548361 0.86 TDO2 (0.46) KDM1ATDO2IDO1ALOX5APFEN1
SCHEMBL26549021 0.86 RXRA (0.44) TDO2IDO1S1PR1TEKRXRA
SCHEMBL26548675 0.86 RXRA (0.44) TDO2IDO1S1PR1TEKRXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AOC1, ODC1, PIEZO1 KDM1A 114/4885TDO2 1074/4885IDO1 2053/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.